Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Marie Skłodowska-Curie Action · Running

CYCLIC-AZA-SULFUR Rapid access to diverse and stereochemically enriched cyclic aza-sulfur(VI) compounds

Coordinator
The Chancellor, Masters and Scholars of the University of Oxford, United Kingdom
Runs
1 March 2027 to 28 February 2029
Status
Running
EU funding
€260k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101273618

What the project is doing

In the project's own words, from its summary on CORDIS.

Compounds with sulfur functional groups are ubiquitous in medicinal chemistry, agrochemistry and beyond. Many of these important molecules are sulfones and sulfonamides, of which the sulfur atom is in the most stable oxidation state VI. Sulfoximines and sulfonimidamides are attained by replacing S=O bonds on these functional groups with S=N bonds. These aza-sulfur(VI) analogues are highly attractive due to extra modularity in N-substituents and manifestation of a sulfur stereocentre, unlocking a rich chemical space for further exploration of new drugs, agrochemicals and chiral reagents.

To accelerate the development of aza-sulfur(VI) with S=N bonds as next-generation pharmacophores, modern studies in synthetic chemistry have led to new methods to access aza-sulfur(VI) compounds of various type with high efficiency and stereoselectivity. Compared to acyclic aza-sulfur(VI) compounds, cyclic aza-sulfur(VI) compounds are heavily underexplored in all applications, yet potentially of much greater value due to a more well-defined and controllable stereochemical framework.

However, there exists no common strategy to access them, especially in the context of stereocontrol. The very few existing reports of stereoselective construction of cyclic aza-sulfur(VI) compounds are restricted to a specific class of attainable scaffold each. The proposed research aims to directly address this shortcoming by developing an efficient, common strategy to a broad range of cyclic aza-sulfur(VI) scaffolds from three very simple chemical components: a carboxylic acid, primary amine, and a commercially available sulfinylamine reagent previously explored in the Willis group.

The synthetic approach will not use any harsh reagents or conditions, and should be fully amenable to both diastereoselective and enantioselective construction of the sulfur stereocentre. This strategy will enable access to new stereoenriched cyclic scaffolds for design of superior drugs, agrochemicals and chiral reagents.

Topics

Who is involved

OrganisationCityCountryRole
The Chancellor, Masters and Scholars of the University of OxfordOxfordUnited KingdomCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI